000 01410 a2200361 4500
005 20250518021503.0
264 0 _c20190528
008 201905s 0 0 eng d
022 _a1532-2777
024 7 _a10.1016/j.mehy.2019.01.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaad, Rahoma E
245 0 0 _aCollagenous colitis development occurs after long standing mucosal healing in IBD with TNF-α inhibitors, and could be due to exaggerated healing response from excess TNF-α inhibition.
_h[electronic resource]
260 _bMedical hypotheses
_cFeb 2019
300 _a90-94 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aColitis, Collagenous
_xmetabolism
650 0 4 _aColitis, Ulcerative
_xgenetics
650 0 4 _aCrohn Disease
_xgenetics
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInflammatory Bowel Diseases
_xgenetics
650 0 4 _aIntestinal Mucosa
_xmetabolism
650 0 4 _aMucous Membrane
_xpathology
650 0 4 _aRemission Induction
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
650 0 4 _aWound Healing
700 1 _aShobar, Rima
700 1 _aMutlu, Ece A
773 0 _tMedical hypotheses
_gvol. 123
_gp. 90-94
856 4 0 _uhttps://doi.org/10.1016/j.mehy.2019.01.004
_zAvailable from publisher's website
999 _c29306564
_d29306564